VISIT OUR COVID-19 HUB

Your Health
GettyImages-1208505315_790x500_1_0.png
GettyImages-1208505315_1000x450_0_0_0.jpg

VISIT OUR COVID-19 HUB

Sharing resources to stay safe and updates on our efforts we hope could bring an end to the global health crisis.

Learn More

The Facts About Pfizer and BioNTech’s COVID-19 Vaccine

Our Science
young_woman_getting_vaccinated_380x500.png
young_woman_getting_vaccinated_1000x450.png

The Facts About Pfizer and BioNTech’s COVID-19 Vaccine

The U.S. FDA authorization of the Pfizer-BioNTech COVID-19 vaccine for emergency use is a significant step forward in our fight against this pandemic.

Learn More

COVID-19 SCIENTIFIC RESOURCES

Our Science
COVID-19 SCIENTIFIC RESOURCES
COVID-19 SCIENTIFIC RESOURCES

COVID-19 SCIENTIFIC RESOURCES

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

More Here

In His Shoes (or Hiking Boots)

Your Health
world_hemophilia_day_article_790X500.png
world_hemophilia_day_article_1000x450.jpg

In His Shoes (or Hiking Boots)

When it comes to making the world a better place for people living with hemophilia—a rare disease characterized by inadequate blood clotting—William Addison doesn’t just talk the talk.

Learn more about William

Search products

Search products, A–Z

Need help paying for Pfizer medicines?

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

Getting to Know Pfizer’s New Chief Medical Officer Aida Habtezion

Our People
aida_habtezion_380x700.png
Aida-1000x450_1.jpg

Getting to Know Pfizer’s New Chief Medical Officer Aida Habtezion

Changing careers in the middle of a pandemic is no small endeavor. But when Aida Habtezion, M.D., learned about the opportunity to serve as Pfizer’s new Chief Medical Officer, she couldn’t pass it up.

Meet Aida

PFIZER’S COMMITMENT TO PATIENTS REFLECTED IN NEW IP PACT

Our Purpose
IP-Pact tile image mobile
IP-Pact tile image

PFIZER’S COMMITMENT TO PATIENTS REFLECTED IN NEW IP PACT

Understand the way we use IP and why it matters for what we do.

See how we are living up to that commitment

Latest News

Pfizer and BioNTech to Provide 500 Million Doses…

U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022 Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility Effort is part of the companies’ recent pledge of two billion doses to ensure global equitable access to the vaccine Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S. government at a not-for-…
Read more